470 related articles for article (PubMed ID: 10383946)
1. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
Int Immunol; 1999 Jul; 11(7):1131-8. PubMed ID: 10383946
[TBL] [Abstract][Full Text] [Related]
2. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
Int Immunol; 1999 Oct; 11(10):1717-24. PubMed ID: 10508191
[TBL] [Abstract][Full Text] [Related]
3. Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy.
Wiedermann U; Jahn-Schmid B; Repa A; Kraft D; Ebner C
Int Arch Allergy Immunol; 1999; 118(2-4):129-32. PubMed ID: 10224359
[TBL] [Abstract][Full Text] [Related]
4. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C
J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907
[TBL] [Abstract][Full Text] [Related]
5. Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses.
Bublin M; Hoflehner E; Wagner B; Radauer C; Wagner S; Hufnagl K; Allwardt D; Kundi M; Scheiner O; Wiedermann U; Breiteneder H
Vaccine; 2007 Dec; 25(50):8395-404. PubMed ID: 17997199
[TBL] [Abstract][Full Text] [Related]
6. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.
Rask C; Holmgren J; Fredriksson M; Lindblad M; Nordström I; Sun JB; Czerkinsky C
Clin Exp Allergy; 2000 Jul; 30(7):1024-32. PubMed ID: 10848926
[TBL] [Abstract][Full Text] [Related]
7. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen.
Wiedermann U; Jahn-Schmid B; Fritsch R; Bauer L; Renz H; Kraft D; Ebner C
Clin Exp Immunol; 1998 Jan; 111(1):144-51. PubMed ID: 9472674
[TBL] [Abstract][Full Text] [Related]
8. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
[TBL] [Abstract][Full Text] [Related]
9. Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice.
Winkler B; Baier K; Wagner S; Repa A; Eichler HG; Scheiner O; Kraft D; Wiedermann U
Clin Exp Allergy; 2002 Jan; 32(1):30-6. PubMed ID: 12002733
[TBL] [Abstract][Full Text] [Related]
10. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J
Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328
[TBL] [Abstract][Full Text] [Related]
13. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
[TBL] [Abstract][Full Text] [Related]
15. Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen.
Jahn-Schmid B; Wiedermann U; Bohle B; Repa A; Kraft D; Ebner C
J Allergy Clin Immunol; 1999 Nov; 104(5):1015-23. PubMed ID: 10550747
[TBL] [Abstract][Full Text] [Related]
16. Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12.
Jahn-Schmid B; Siemann U; Zenker A; Bohle B; Messner P; Unger FM; Sleytr UB; Scheiner O; Kraft D; Ebner C
Int Immunol; 1997 Dec; 9(12):1867-74. PubMed ID: 9466314
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of mice with olive pollen allergen Ole e 1 induces a Th2 response.
Batanero E; Barral P; Villalba M; Rodríguez R
Int Arch Allergy Immunol; 2002 Apr; 127(4):269-75. PubMed ID: 12021545
[TBL] [Abstract][Full Text] [Related]
18. Intranasal sensitization of Japanese cedar pollen by the co-administration of low doses of cholera toxin but not its recombinant B subunit to mice.
Hirai T; Hashiguchi S; Torigoe N; Toda Y; Ito Y; Sugimur K
Microbiol Immunol; 2000; 44(4):259-66. PubMed ID: 10832969
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora.
Repa A; Kozakova H; Hudcovic T; Stepankova R; Hrncir T; Tlaskalova-Hogenova H; Pollak A; Wiedermann U
Immunol Lett; 2008 Apr; 117(1):50-6. PubMed ID: 18241932
[TBL] [Abstract][Full Text] [Related]
20. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
